Universitätsklinikum Schleswig-Holstein (UKSH)

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea (2022) Allard P, Alhaj N, Lobitz S, Cario H, Jarisch A, Grosse R, Oevermann L, et al. Journal article Detection of neuron-derived pathological alpha-synuclein in blood (2022) Kluge A, Bunk J, Schaeffer E, Drobny A, Xiang W, Knacke H, Bub S, et al. Journal article (1 -> 3)-beta-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial (2022) Bloos F, Held J, Kluge S, Simon P, Kogelmann K, De Heer G, Kuhn SO, et al. Journal article Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study (2022) Welland S, Leyh C, Finkelmeier F, Jefremow A, Shmanko K, Gonzalez-Carmona MA, Kandulski A, et al. Journal article In vitro validation and characterization of pulsed inhaled nitric oxide administration during early inspiration (2022) Pickerodt PA, Hofferberth MBT, Busch T, Russ M, Taher M, Boemke W, Weber-Carstens S, et al. Journal article PREDICTING OUTCOMES IN SYSTEMIC SCLEROSIS: STRATIFICATION BY AUTO-ANTIBODIES OUTPERFORMS CUTANEOUS SUBSETTING IN THE EUSTAR COHORT (2022) Elhai M, Boubaya M, Sritharan N, Balbir-Gurman A, Siegert E, Hachulla E, De Vries-Bouwstra J, et al. Conference contribution Update Breast Cancer 2022 Part 2 - Advanced Stage Breast Cancer (2022) Müller V, Welslau M, Lüftner D, Schütz F, Stickeler E, Fasching P, Janni W, et al. Journal article, Review article Generalisierte pustulöse Psoriasis: Überblick zum Status quo und Ergebnisse einer Diskussionsrunde (2022) Reich K, Augustin M, Gerdes S, Ghoreschi K, Kokolakis G, Mößner R, Mrowietz U, et al. Journal article, Review article Current research and unmet needs in allergy and immunology in Germany: report presented by the DGfI and DGAKI task force Allergy & Immunology (2022) Albrecht M, Schaub B, Gilles S, Koehl J, Altrichter S, Vöhringer D, Spillner E, et al. Journal article, Editorial Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab (2022) Gerdes S, Asadullah K, Hoffmann M, Korge B, Mortazawi D, Wegner S, Personke Y, et al. Journal article